Asia presents huge opportunities for the growth of virus filtration owing to its low labor and raw material costs, rising life science and research activities, government support, and technological integration and advancements. The rise in R&D expenditure, growth of biopharmaceutical industry, and increasing government support for pharmaceutical and biotechnology industry are driving factors of the virus filtration market. Meanwhile, growing adoption of single-use technologies is an upcoming trend in the virus filtration market. Single-use technologies eliminate cleaning validation steps, providing significant time and cost savings. Thus, owing to its advantages over other conventional technologies, the demand for this technology is estimated to grow in the coming years.
Virus Filtration is an important operation in the biopharmaceutical industry, as it not only ensures if the products are adequately purified and fit for consumption, but also helps to optimize process economics and prevent loss of valuable product. The filtration process is used in a variety of biologicals, medical devices, water purification, and air purification. This market studies includes kits and reagents, filtration systems, other products and services for filtration process by various end users like, pharmaceutical & biotechnology companies, contract research organizations, academic research institutes and medical devices companies.
The product segments of the virus filtration will be important revenue pockets of the virus filtration market in the forecast period (2015–2020). The kits and reagents, filtration systems, other products and services are the major products segments of the virus filtration market. The kits and reagents products segment accounted for the largest share of the virus filtration market, in 2015 and it is also expected to grow at the highest rate during the forecast period.
North America accounted for the largest share of the global virus filtration market in 2015. However, the Asian market is expected to grow at the highest rate during the forecast period and represents new revenue pockets for the virus filtration market. The expansion of leading virus filtration companies in Asia will enhance the market in this region. In addition, according to WIPO, Asia accounted for 53.1% of all pharmaceutical patents and 50.4% of all biotechnology patents granted in 2012. High number of biotechnology patent grants and rapid growth in the pharmaceutical and biotechnology industries in Asian countries will drive the virus filtration market in this region.
